Shellie D. Ellis

1.1k total citations
51 papers, 650 citations indexed

About

Shellie D. Ellis is a scholar working on General Health Professions, Economics and Econometrics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Shellie D. Ellis has authored 51 papers receiving a total of 650 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in General Health Professions, 17 papers in Economics and Econometrics and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Shellie D. Ellis's work include Economic and Financial Impacts of Cancer (10 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers) and Global Cancer Incidence and Screening (7 papers). Shellie D. Ellis is often cited by papers focused on Economic and Financial Impacts of Cancer (10 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers) and Global Cancer Incidence and Screening (7 papers). Shellie D. Ellis collaborates with scholars based in United States, Canada and United Kingdom. Shellie D. Ellis's co-authors include Sally A. Shumaker, Lars R. McNaughton, Denise E. Bonds, Sultan Barakat, William J. Sieber, Earl Schwartz, Ann P. Walker, Cynthia S. Rand, Sarah A. Birken and Mark A. Hall and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Shellie D. Ellis

45 papers receiving 621 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shellie D. Ellis United States 14 189 170 119 86 78 51 650
Susanne Schmidt United States 17 95 0.5× 211 1.2× 130 1.1× 145 1.7× 129 1.7× 63 905
Anne Douglas United Kingdom 15 200 1.1× 189 1.1× 50 0.4× 46 0.5× 25 0.3× 30 961
Liv Marit Valen Schougaard Denmark 13 256 1.4× 156 0.9× 118 1.0× 138 1.6× 16 0.2× 37 688
Gaetano Forte United States 10 207 1.1× 287 1.7× 167 1.4× 234 2.7× 127 1.6× 21 785
Holly Mead United States 14 261 1.4× 207 1.2× 94 0.8× 86 1.0× 12 0.2× 29 664
Safa Abdalla United States 15 114 0.6× 114 0.7× 38 0.3× 41 0.5× 38 0.5× 52 745
Linda Lillington United States 16 265 1.4× 216 1.3× 75 0.6× 292 3.4× 46 0.6× 25 985
James V. Davis United States 15 381 2.0× 91 0.5× 92 0.8× 80 0.9× 100 1.3× 35 751
Padraig Dixon United Kingdom 16 136 0.7× 146 0.9× 135 1.1× 40 0.5× 87 1.1× 39 568
Margaret Nolan United States 14 125 0.7× 97 0.6× 47 0.4× 55 0.6× 51 0.7× 39 729

Countries citing papers authored by Shellie D. Ellis

Since Specialization
Citations

This map shows the geographic impact of Shellie D. Ellis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shellie D. Ellis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shellie D. Ellis more than expected).

Fields of papers citing papers by Shellie D. Ellis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shellie D. Ellis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shellie D. Ellis. The network helps show where Shellie D. Ellis may publish in the future.

Co-authorship network of co-authors of Shellie D. Ellis

This figure shows the co-authorship network connecting the top 25 collaborators of Shellie D. Ellis. A scholar is included among the top collaborators of Shellie D. Ellis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shellie D. Ellis. Shellie D. Ellis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gupta, Aditi, Shellie D. Ellis, Jessica E. Reed, et al.. (2025). Relationships Matter: Exploring the Impact of Patients’ Familial, Community, and Provider Relationships on Hypertension Management. Journal of General Internal Medicine. 41(3). 716–725.
2.
Gupta, Aditi, Shellie D. Ellis, Jessica E. Reed, et al.. (2025). Organizational Determinants to Hypertension Management: Adapting a Health Equity Framework to Examine Processes at Two Academic Health Systems. Journal of General Internal Medicine. 40(6). 1255–1264. 1 indexed citations
4.
Ellis, Shellie D., Joanna Veazey Brooks, Sarah A. Birken, et al.. (2023). Determinants of targeted cancer therapy use in community oncology practice: a qualitative study using the Theoretical Domains Framework and Rummler-Brache process mapping. SHILAP Revista de lepidopterología. 4(1). 66–66. 1 indexed citations
5.
Gupta, Aditi, Shellie D. Ellis, Crystal Burkhardt, et al.. (2022). Implementing a home-based virtual hypertension programme—a pilot feasibility study. Family Practice. 40(2). 414–422. 8 indexed citations
6.
Ellis, Shellie D., Riha Vaidya, Joseph M. Unger, et al.. (2022). Access to urologists for participation in research: An analysis of NCI's Community Oncology Research Program landscape survey. Contemporary Clinical Trials Communications. 29. 100981–100981. 2 indexed citations
7.
Ellis, Shellie D., et al.. (2021). Physician perceived barriers and facilitators for self-measured blood pressure monitoring- a qualitative study. PLoS ONE. 16(8). e0255578–e0255578. 12 indexed citations
9.
Neil‐Sztramko, Sarah, Jennifer Leng, Philip Walker, et al.. (2020). Use of implementation science in tobacco control intervention studies in the USA between 2000 and 2020: a scoping review protocol. BMJ Open. 10(11). e038617–e038617. 4 indexed citations
10.
Ellis, Shellie D., et al.. (2019). Science in the Heartland: Exploring determinants of offering cancer clinical trials in rural-serving community urology practices. Urologic Oncology Seminars and Original Investigations. 37(8). 529.e9–529.e18. 15 indexed citations
11.
Antonelli, Kaitlyn R., et al.. (2017). Insurance denials for cancer clinical trial participation after the Affordable Care Act mandate. Cancer. 123(15). 2893–2900. 17 indexed citations
12.
Ellis, Shellie D.. (2015). TREATMENT DECISION MAKING IN LOW-RISK PROSTATE CANCER: RECRUITMENT AND DATA COLLECTION FEASIBILITY. 2 indexed citations
13.
Birken, Sarah A., Shellie D. Ellis, Jennifer S. Walker, et al.. (2015). Guidelines for the use of survivorship care plans: a systematic quality appraisal using the AGREE II instrument. Implementation Science. 10(1). 63–63. 28 indexed citations
14.
Ellis, Shellie D., et al.. (2015). Gonadotropin-releasing hormone agonist overuse: urologists’ response to reimbursement and characteristics associated with persistent overuse. Prostate Cancer and Prostatic Diseases. 18(2). 173–181. 10 indexed citations
15.
Birken, Sarah A., et al.. (2014). Potential determinants of health-care professionals’ use of survivorship care plans: a qualitative study using the theoretical domains framework. Implementation Science. 9(1). 167–167. 26 indexed citations
16.
Rosenberger, Erica L., David C. Goff, Caroline S. Blackwell, et al.. (2009). Implementing a palm pilot intervention for primary care providers: Lessons learned. Contemporary Clinical Trials. 30(4). 321–325. 4 indexed citations
17.
Harrison, Helen, Barbara Harrison, Ann P. Walker, et al.. (2008). Screening for Hemochromatosis and Iron Overload: Satisfaction with Results Notification and Understanding of Mailed Results in Unaffected Participants of the HEIRS Study. Genetic Testing. 12(4). 491–500. 8 indexed citations
18.
Ellis, Shellie D., Alain G. Bertoni, Denise E. Bonds, et al.. (2006). Value of recruitment strategies used in a primary care practice-based trial. Contemporary Clinical Trials. 28(3). 258–267. 61 indexed citations
19.
Ellis, Shellie D., Sally A. Shumaker, William J. Sieber, & Cynthia S. Rand. (2000). Adherence to Pharmacological Interventions. Controlled Clinical Trials. 21(5). S218–S225. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026